← Leaderboards
Anna N Yaroslavsky
Massachusetts General Hospital
$1,956,886
Attributed
$1,956,886
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $346.7K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,956,886 · 3
By mechanism
R01$1,018,154 · 1
R33$572,112 · 1
R21$366,620 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael R Hamblin$6,140,037
- Brian J Bacskai$26,389,294
- Gian Paolo Dotto$22,106,352
- Udo Hoffmann$17,171,978
- Anand T.n. Kumar$7,313,344
Others in their field
Top investigators on “Fluorescence Polarization”
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Tobias Meyer · Weill Medical Coll Of Cornell Univ$15,171,757
- Yale E Goldman · University Of Pennsylvania$14,922,229
- David G. Drubin · University Of California Berkeley$13,633,079
- Rudolf Oldenbourg · Marine Biological Laboratory$10,391,745
- Stanley B Prusiner · University Of California San Francisco$9,398,643
Research focus
Fluorescence PolarizationSquamous Cell CarcinomaPilot TrialLesionOptic ImagingPathologyImaging DeviceDevicesIn VitroIn VivoMicroscopeNon-Invasive Cancer DetectionOpticsDesignDetectionFluorescenceHistopathologyImageIn SituDyesEquipmentEvaluationExcisionMalignant Neoplasms
Grant awards (7)
Towards In Situ Optical Pathology of Nonmelanoma Skin Cancers$269,115
R33 · FY2010 · CA · contact PI
Towards In Situ Optical Pathology of Nonmelanoma Skin Cancers$302,997
R33 · FY2009 · CA · contact PI
Towards In Situ Optical Pathology of Nonmelanoma Skin Cancers$164,553
R21 · FY2008 · CA · contact PI
Towards In Situ Optical Pathology of Nonmelanoma Skin Cancers$202,067
R21 · FY2007 · CA · contact PI
Optical Mapping of Nonmelanoma Skin Cancers$346,675
R01 · FY2005 · EB
Optical Mapping of Nonmelanoma Skin Cancers$350,325
R01 · FY2004 · EB
Optical Mapping of Nonmelanoma Skin Cancers$321,154
R01 · FY2003 · EB